首页 正文

Innovations in Molecular Biomarkers and Biomaterial-Based Immunotherapies for Head & Neck Cancer

{{output}}
Purpose of review: Oral squamous cell carcinoma (OSCC) survival rates have remained stagnant due to a lack of targeted therapies and diagnostic tools. Patient risk is currently determined solely through clinicopathologic features... ...